glp-1 agonist therapy consultation preparation Weight Loss Pacific Northwest How to use GLP-1 receptor

Every appointment operates under physician oversight through an in-house medical direction model

If you have liver disease, youre not alone

10.1111/jnc.70073 29 FedericiL.MasulliM.De LaurenziV.AllocatiN

PubMed laboratory research record [PMID: 9522640] PubMed record related to this compound for laboratory literature review

Loading Phase (Weeks 1-4): 2 to 2.5 mg twice weekly (Monday/Thursday schedule) Maintenance Phase (Weeks 5+): 2 mg once every 7 to 14 days Administration: Subcutaneous injection, location flexible due to systemic distribution Total Cycle: 8 to 12 weeks with 4 to 8 weeks off between cycles The convenience of twice-weekly dosing during loading and weekly or biweekly dosing during maintenance fits easily into Retatrutide schedules